Home Medicine Do we really need high-sensitive troponin immunoassays in the emergency department? Definitely, yes!
Article
Licensed
Unlicensed Requires Authentication

Do we really need high-sensitive troponin immunoassays in the emergency department? Definitely, yes!

  • Karl J. Lackner EMAIL logo
Published/Copyright: August 20, 2013

Abstract

Cardiac troponins have changed our understanding of myocardial infarction profoundly during the past 20 years. In fact release of cardiac troponin into the blood has become part of the definition of myocardial infarction. Diagnostics and treatment have taken these new insights into account. The novel high-sensitive assays for cardiac troponins that are available recently clearly constitute a significant further improvement of analytical performance. In addition, the still incomplete clinical data available indicate that these assays will also further improve patient care in many ways. In summary, cardiac troponins are a great example of the potential impact of analytical performance of diagnostic tests on patient care and patient outcome.


Corresponding author: Dr. Karl J. Lackner, Institute of Clinical Chemistry and Laboratory Medicine, University Medical Centre Mainz, Langenbeckstrasse 1, 55131 Mainz, Germany, Phone: +49 6131 177190, Fax: +49 6131 176627, E-mail:

References

1. Tate JR. Troponin revisited 2008: assay performance. Clin Chem Lab Med 2008;46:1489–500.10.1515/CCLM.2008.292Search in Google Scholar PubMed

2. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009;361:858–67.10.1056/NEJMoa0900428Search in Google Scholar PubMed

3. Keller T, Zeller T, Peetz D, Tzikas S, Roth A, Czyz E, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009;361:868–77.10.1056/NEJMoa0903515Search in Google Scholar PubMed

4. Apple FS. Collinson PO for the IFCC Task Force on Clinical Applications of Cardiac Biomarkers. Clin Chem 2012;58:54–61.10.1373/clinchem.2011.165795Search in Google Scholar PubMed

5. Spencer CA, Takeuchi M, Kazarosyan M. Current status and performance goals for serum thyrotropin (TSH) assays. Clin Chem 1996;42:140–5.10.1093/clinchem/42.1.140Search in Google Scholar

6. Giannitsis E, Becker M, Kurz K, Hess G, Zdunek D, Katus HA. High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission. Clin Chem 2010;56:642–50.10.1373/clinchem.2009.134460Search in Google Scholar PubMed

7. Keller T, Zeller T, Ojeda FM, Tzikas S, Lillpopp L, Sinning C, et al. Serial changes in highly sensitive troponin I assays and early diagnosis of myocardial infarction. J Am Med Assoc 2011;306:2684–93.10.1001/jama.2011.1896Search in Google Scholar PubMed

8. Hamm CW, Bassand J-P, Agewall S, Bax J, Boersma E, Bueno H, et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2011;32:2999–3054.10.1093/eurheartj/ehr236Search in Google Scholar PubMed

9. Reichlin T, Schindler C, Drexler B, Twerenbold R, Reiter M, Zellweger C, et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch Intern Med 2012;172:1211–8.10.1001/archinternmed.2012.3698Search in Google Scholar PubMed

10. Reichlin T, Twerenbold R, Maushart C, Reiter M, Moehring B, Schaub N, et al. Risk stratification in patients with unstable angina using absolute serial changes of 3 high-sensitive troponin assays. Am Heart J 2013;165:371–8.e3.10.1016/j.ahj.2012.11.010Search in Google Scholar PubMed

11. Lackner KJ. Laboratory diagnostics of myocardial infarction – troponins and beyond. Clin Chem Lab Med 2013;51:83–9.10.1515/cclm-2012-0572Search in Google Scholar PubMed

Received: 2013-7-5
Accepted: 2013-7-30
Published Online: 2013-8-20
Published in Print: 2014-2-1

©2014 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. The ten commandments of laboratory testing for emergency physicians
  4. Review
  5. Critical role of RAGE in lung physiology and tumorigenesis: a potential target of therapeutic intervention?
  6. Opinion Papers
  7. Do we really need high-sensitive troponin immunoassays in the emergency department? Definitely, yes!
  8. Do we really need high-sensitivity troponin immunoassays in the emergency department? Maybe not
  9. General Clinical Chemistry and Laboratory Medicine
  10. Cortisol and cortisone ratio in urine: LC-MS/MS method validation and preliminary clinical application
  11. Urinary neutrophil gelatinase-associated lipocalin (NGAL) excretion increases in normal pregnancy but not in preeclampsia
  12. Influence of urine volume on the assessment of intestinal permeability in affected children by multiple sugar probes
  13. Measurement of amino terminal propeptide of type III procollagen (PIIINP) employing the ADVIA Centaur platform. Validation, reference interval and comparison to UniQ RIA
  14. Cancer Diagnostics
  15. Enrichment and enumeration of circulating tumor cells by efficient depletion of leukocyte fractions
  16. Immunological screening for tumor cells in serous body fluids has added value with the CELL-DYN Sapphire
  17. Cardiovascular Diseases
  18. The value of clinical and laboratory diagnostics for chest pain patients at the emergency department
  19. The concentration of high-sensitivity troponin I, galectin-3 and NT-proBNP substantially increase after a 60-km ultramarathon
  20. Autoantibody prevalence with an improved immunoassay for detecting cardiac troponin-specific autoantibodies
  21. Increased B-type natriuretic peptide levels in early-onset versus late-onset preeclampsia
  22. Association of the GCKR rs780094 polymorphism with metabolic traits including carotid intima-media thickness in Japanese community-dwelling men, but not in women
  23. Infectious Diseases
  24. Analysis of antibody response (IgM, IgG, IgG3) to Chikungunya virus using panel of peptides derived from envelope protein for serodiagnosis
  25. Letters to the Editor
  26. A short story on how the H-index may change the fate of scientists and scientific publishing
  27. A new and effective way for preventing pre-analytical laboratory errors
  28. Digital immunofluorescence enables automated detection of antinuclear antibody endpoint titers avoiding serial dilution
  29. Multicenter method evaluation of the ARK™ Methotrexate Immunoassay
  30. Haemoglobinopathies in nonendemic areas in recent years
  31. Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: some results
  32. Effect of recalibration of the hs-TnT assay on diagnostic performance
Downloaded on 7.3.2026 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2013-0604/html
Scroll to top button